Latest Virax Biolabs News & Updates

See the latest news and media coverage for Virax Biolabs. We track all announcements, press releases, and industry mentions in real time, all in one place.

Virax Biolabs

Immunology research company

viraxbiolabs.com

Headquarters: Motherwell, United Kingdom
Founded year: 2013
Company type: Public company
Number of employees: 30–50
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Virax Biolabs

In short: Virax Biolabs strengthened its financial position through capital raises and restored Nasdaq compliance while advancing its T-cell assay.

Company announcements

July 22 Virax Biolabs

Virax Biolabs highlights Bundibugyo Ebola outbreak

The Bundibugyo strain in the DRC lacks a licensed vaccine or specific treatment, emphasizing rapid diagnostics.

July 9 Virax Biolabs

Virax Biolabs signs commercial supply agreement with Fosun Diagnostics

The agreement covers six Southeast Asian markets and supports near-term revenue opportunities through purchase orders.

July 9 Virax Biolabs

Virax Biolabs announces $3.3M preferred investment option exercise

The company will issue new warrants and use proceeds for working capital

June 24 Virax Biolabs

Virax Biolabs announces 1-for-25 share consolidation

The consolidation aims to regain Nasdaq compliance and will be effective June 26, 2026.

Media coverage

August 2 The Globe and Mail

Virax Biolabs Calls August 14 EGM to Approve Major Share Capital Increase

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities...

July 9 The Globe and Mail

Virax Biolabs Raises $3.3 Million via Exercise of Investment Options and Issues New Warrants

Detailed price information for Virax Biolabs Group Limited (VRAX-Q) from The Globe and Mail including charting and trades.

July 9 The Globe and Mail

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

Detailed price information for Virax Biolabs Group Limited (VRAX-Q) from The Globe and Mail including charting and trades.

July 9 Yahoo Finance

Why Did Virax Biolabs Stock Triple In One Session?

Virax Biolabs Group Limited (NASDAQ:VRAX) stock is up during Thursday's premarket session, as the company has signed a multi-country commercial supply agreement with Fosun Diagnostics...

Never miss news about Virax Biolabs

Track Virax Biolabs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Virax Biolabs competitors & trending companies

Browse news for competitors to Virax Biolabs and other trending companies.